The following video is from Monday's Investor Beat, in which host Alison Southwick and Motley Fool analysts Matt Koppenheffer and Matt Argersinger dissect the hardest-hitting investing stories of the day.
Biotech giant Amgen (NASDAQ: AMGN ) announced today that it's acquiring Onyx Pharmaceuticals (UNKNOWN: ONXX.DL ) for $10.4 billion. In our lead story on Investor Beat, our two Matts discuss the acquisition and look at whether M&A in general is good news for investors.
It's no secret that biotech stocks have been soaring recently, but the best investment strategy is to pick great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" not only shares stocks that could help you build long-term wealth, but also winning strategies that every investor should know. Click here to grab your free copy today.